Key to symbols
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
1.5. Chronic bowel disorders
1.5.6. Medicines for Short Bowel Syndrome
Total Formulary
TEDUGLUTIDE (REVESTIVE) (injection)
Restrictions:
Restricted to specialist use in adults with short bowel syndrome (SBS) who are stable following a period of intestinal adaptation after surgery in accordance with locally agreed guidance notes as outlined in the prescribing notes below.
Prescribing Notes:
- Only for prescribing by the GRI Intestinal Failure team for patients with short bowel syndrome after all other treatment has been optimised
- Candidates should have stable Parenteral Nutrition (PN)/ intravenous (IV) fluid prescriptions for at least two years before treatment is initiated
- A reduction in requirement for parenteral nutrition will measure the success of treatment and support ongoing prescribing